BCL2 and breast cancer: Overexpression of BCL-2 occurs in approximately 41% of TNBC cases.5 Research has outlined a relationship between BCL-2 expression and increased chance of survival in TNBC patients,6 but the way in which BCL-2 could function as a therapeutic target for BC is not concrete.